| 12th May 2022 7:00 am |
RNS |
Transaction in Own Shares |
| 11th May 2022 7:00 am |
RNS |
Transaction in Own Shares |
| 10th May 2022 7:00 am |
RNS |
Transaction in Own Shares |
| 9th May 2022 7:00 am |
RNS |
PRTC Share Buyback Programme Commences Purchases |
| 5th May 2022 7:00 am |
RNS |
PRTC Announces Share Buyback Programme Up to $50M |
| 4th May 2022 11:35 am |
RNS |
Gelesis Presents GS200 Weight Loss Data at ECO |
| 3rd May 2022 7:00 am |
RNS |
Total Voting Rights |
| 29th Apr 2022 11:05 am |
RNS |
Gelesis Data: Therapeutic Shows Gut Health Benefit |
| 26th Apr 2022 7:00 am |
RNS |
PRTC Final Results & Publication of Annual Report |
| 13th Apr 2022 4:44 pm |
RNS |
PRTC's Vedanta Publishes VE303 Data |
| 12th Apr 2022 12:05 pm |
RNS |
Akili Depression Data Published in AJP |
| 12th Apr 2022 7:00 am |
RNS |
Glyph: 20x Oral Bioavailability of Buprenorphine |
| 7th Apr 2022 7:00 am |
RNS |
Notice of Results |
| 1st Apr 2022 7:00 am |
RNS |
Total Voting Rights |
| 24th Mar 2022 7:00 am |
RNS |
PRTC Appoints Merck Vet to BOD & Audit Committee |
| 17th Mar 2022 1:05 pm |
RNS |
Akili Adds Gaming Vet as Chief Product Officer |
| 16th Mar 2022 10:35 am |
RNS |
Gelesis: Record-Breaking Plenity Prescriptions |
| 8th Mar 2022 12:05 pm |
RNS |
Akili Named to World's Most Innovative Companies |
| 18th Feb 2022 4:30 pm |
RNS |
Holding(s) in Company |
| 17th Feb 2022 12:05 pm |
RNS |
Akili Data: Enhanced Brain Activity in Kids w/ADHD |
| 15th Feb 2022 7:00 am |
RNS |
PRTC's Akili Files Registration Statement on S-4 |
| 10th Feb 2022 12:00 pm |
RNS |
PRTC to Present at Leerink Healthcare Conference |
| 4th Feb 2022 7:00 am |
RNS |
PDMR DEALING - PURCHASE OF SHARES |
| 31st Jan 2022 11:50 am |
RNS |
PRTC's Gelesis Launches Plenity Media Campaign |
| 26th Jan 2022 12:02 pm |
RNS |
PRTC’s Akili to Become Public & $162M Funding |
| 14th Jan 2022 7:00 am |
RNS |
PRTC's Gelesis to Debut on NYSE Today Ticker GLS |
| 7th Jan 2022 12:00 pm |
RNS |
PureTech to Present at JPM Healthcare Conference |
| 6th Jan 2022 7:00 am |
RNS |
LYT-100 Shows Improved AE Profile vs Pirfenidone |
| 5th Jan 2022 12:05 pm |
RNS |
Gelesis Adds to BOD & Declared Effective by SEC |
| 20th Dec 2021 7:00 am |
RNS |
PDMR DEALING - PURCHASE OF SHARES |
| 16th Dec 2021 7:00 am |
RNS |
PRTC Provides Recap Ahead of Catalyst-Rich 2022 |
| 8th Dec 2021 12:00 pm |
RNS |
PRTC Presents Data at ACNP Conference For LYT-300 |
| 7th Dec 2021 12:00 pm |
RNS |
PRTC's Lymphatic Platform Candidate Human Study |
| 1st Dec 2021 12:10 pm |
RNS |
PRTC: Gelesis' Plenity Now Broadly Available in US |
| 1st Dec 2021 7:00 am |
RNS |
Total Voting Rights |
| 18th Nov 2021 12:10 pm |
RNS |
PRTC's Gelesis Receives $30M Plenity Order from Ro |
| 16th Nov 2021 12:00 pm |
RNS |
PRTC Publishes Previous LYT-100 MAD Study Results |
| 15th Nov 2021 12:00 pm |
RNS |
PRTC Presents at Two Upcoming Investor Conferences |
| 12th Nov 2021 12:00 pm |
RNS |
PRTC Presents Immunooncology Ph 1/2 Trial at SITC |
| 11th Nov 2021 12:00 pm |
RNS |
FDA Grants PRTC's LYT-200 Orphan Drug Designation |
